Maxalt Tablet
Product Images NDC 78206-142

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Maxalt (NDC 78206-142). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Organon Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Rizatriptan Benzoate Chemical Structure (Maxalt 01)

FDA Label Image

Image Of Figure 1 (Maxalt 02)

Image Of Figure 1 (Maxalt 02)
The text provides a graph showing the estimated probability of response to different medications, including MAXALT 5mg, MAXALT 10mg, and Placebo, at different hours post-dose. The graph's x-axis represents time in hours post-dose, while the y-axis represents the probability of response percentage. It presents useful information for evaluating the effectiveness of these medications.*
FDA Label Image

Image Of Figure 2 (Maxalt 03)

Image Of Figure 2 (Maxalt 03)
The text appears to be a graph displaying the estimated probability of remedication or rescue for three different medications (Placebo, MAXALT 5 mg and MAXALT 10 mg) over a period of time (10-24 hours post-dose). The graph also includes two lines labeled "PR" and "PP" with percentages ranging from 0 to 100. Without additional context, it is unclear what the lines represent.*
FDA Label Image

Image Of Figure 3 (Maxalt 04)

Image Of Figure 3 (Maxalt 04)
This is a chart that shows the estimated probability of response to a medication called MAXALT-MLT in 5mg and 10mg doses compared to a placebo. The chart has time on the x-axis and the probability of response on the y-axis. The probability of response ranges from 0% to 100% and the time post-dose ranges from 0 to 2 hours.*
FDA Label Image

Image Of Figure 4 (Maxalt 05)

Image Of Figure 4 (Maxalt 05)
This is a graph showing the effectiveness of a placebo and two dosages of MAXALT-MLT (5mg and 10mg) over a course of 24 hours following dosing. The efficacy is measured on a scale from 0 to 100%.*
FDA Label Image

Image Of Figure 5 (Maxalt 06)

FDA Label Image

Principal Display Panel (10 mg Tablet Pouch Carton)

Principal Display Panel (10 mg Tablet Pouch Carton)
This is a package of Maxalt 10 mg tablets from Organon. The tablets come in a pack of 18 and are equivalent to 10 mg of zolmitriptan. The package has a pharmacy label area, and the product is identifiable by its serial number, barcode, expiry and lot number.*
FDA Label Image

Principal Display Panel (10 mg Tablet Case Carton)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.